While CTCAs can detect epicardial atherosclerotic plaque with excellent sensitivity, microvascular disease cannot be identified on CT and may have an impact on serum levels of TRAIL, IL-18, and OPG, particularly considering their known associations with metabolic and endothelial dysfunction [15,32,46,47]. This evidence concerns the gene IL18 and endothelial dysfunction.